Astegolimab
- Generic Name
- Astegolimab
- Brand Names
- -
- Drug Type
- Biotech
- Chemical Formula
- -
- CAS Number
- 2173054-79-8
- Unique Ingredient Identifier
- 27TW751DTH
- Background
Astegolimab is under investigation in clinical trial NCT04386616 (A Study to Evaluate the Safety and Efficacy of MSTT1041A (Astegolimab) or UTTR1147A in Patients With Severe COVID-19 Pneumonia).
- Associated Conditions
- -
- Associated Therapies
- -
A Study to Evaluate the Effect of Injection Site on PK of Astegolimab in Healthy Subjects
- First Posted Date
- 2024-06-17
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 78
- Registration Number
- NCT06462118
- Locations
- ๐บ๐ธ
Covance Research Unit - Daytona, Daytona Beach, Florida, United States
๐บ๐ธCovance Clinical Research Unit, Inc, Madison, Wisconsin, United States
๐บ๐ธCovance Research Unit - Dallas, Dallas, Texas, United States
A Study to Evaluate the Long-Term Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease (COPD)
- First Posted Date
- 2023-05-26
- Last Posted Date
- 2024-11-25
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 2000
- Registration Number
- NCT05878769
- Locations
- ๐ฆ๐ท
Fundacion Scherbovsky, Mendoza, Argentina
๐ฆ๐ทCentro Respiratorio Quilmes, Quilmes, Argentina
๐ง๐ฌMedical Center New rehabilitation center EOOD, Stara Zagora, Bulgaria
A Study to Evaluate Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- Conditions
- Interventions
- First Posted Date
- 2022-10-27
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Hoffmann-La Roche
- Target Recruit Count
- 1290
- Registration Number
- NCT05595642
- Locations
- ๐บ๐ธ
Pinnacle Research Group, Anniston, Alabama, United States
๐บ๐ธAllerVie Clinical Research, Birmingham, Alabama, United States
๐บ๐ธSynexus Clinical Research US, Inc. - Birmingham, Birmingham, Alabama, United States
A Study to Evaluate the Efficacy and Safety of Astegolimab in Participants With Chronic Obstructive Pulmonary Disease
- Conditions
- Interventions
- First Posted Date
- 2021-09-08
- Last Posted Date
- 2024-10-24
- Lead Sponsor
- Genentech, Inc.
- Target Recruit Count
- 1440
- Registration Number
- NCT05037929
- Locations
- ๐ณ๐ฟ
Aotearoa Clinical Trials Trust, Auckland, New Zealand
๐บ๐ธSEC Clinical Research LLC - Dothan 2 - ClinEdge - PPDS, Dothan, Alabama, United States
๐บ๐ธJasper Summit Research LLC, Jasper, Alabama, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.